Abstract
The objective of this study was to determine whether the interaction between type of serious mental illness (SMI) and pre-treatment drinking severity, assessed by ethyl glucuronide (EtG), predicts EtG-positive urine samples submitted during treatment in outpatients with co-occurring alcohol dependence and SMI. Seventy-nine participants were randomized to treatment-as-usual or treatment-as-usual and contingency management (CM) targeting alcohol abstinence. Generalized estimating equations were used to assess the interaction of pre-treatment drinking (heavy drinking or light drinking) and SMI diagnosis (major depression, bipolar, or schizophrenia-spectrum disorders) across a 12-week treatment period. In the overall sample, the interaction of drinking severity and SMI diagnosis (p = 0.006) was associated with alcohol abstinence. Exploratory analyses of the interaction term among participants randomized to CM (n = 40; p = 0.008) were associated with alcohol abstinence during CM. Type of SMI diagnosis was associated with treatment outcomes in individuals who engaged in heavy drinking, but not light drinking, prior to treatment.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Angelo, F. N., McDonell, M. G., Lewin, M. R., Srebnik, D., Lowe, J., Roll, J., & Ries, R. (2013). Predictors of stimulant abuse treatment outcomes in severely mentally ill outpatients. Drug and Alcohol Dependence, 131(1), 162–165.
Barrowclough, C., Haddock, G., Wykes, T., Beardmore, R., Conrod, P., Craig, T., et al. (2010). Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: randomised controlled trial. British Medical Journal (Clinical Research Ed.), 341, c6325. https://doi.org/10.1136/bmj.c6325.
Bellack, A. S., Bennett, M. E., Gearon, J. S., Brown, C. H., & Yang, Y. (2006). A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental illness. Archives of General Psychiatry, 63(4), 426–432.
Bradizza, C. M., Stasiewicz, P. R., & Dermen, K. H. (2014). Behavioral interventions for individuals dually diagnosed with a severe mental illness and a substance use disorder. Current Addiction Reports, 1(4), 243–250.
Buckley, P. F., & Brown, E. S. (2006). Prevalence and consequences of dual diagnosis. The Journal of Clinical Psychiatry, 67(7), 1–1.
Compton III, W. M., Cottler, L. B., Jacobs, J. L., Ben-Abdallah, A., & Spitznagel, E. L. (2003). The role of psychiatric disorders in predicting drug dependence treatment outcomes. American Journal of Psychiatry, 160(5), 890–895.
Davis, L., Uezato, A., Newell, J. M., & Frazier, E. (2008). Major depression and comorbid substance use disorders. Current Opinion in Psychiatry, 21(1), 14–18. https://doi.org/10.1097/YCO.0b013e3282f32408.
García-Fernández, G., Secades-Villa, R., García-Rodríguez, O., Peña-Suárez, E., & Sánchez-Hervás, E. (2013). Contingency management improves outcomes in cocaine-dependent outpatients with depressive symptoms. Experimental and Clinical Psychopharmacology, 21(6), 482.
Gonzalez, V. M., Bradizza, C. M., Vincent, P. C., Stasiewicz, P. R., & Paas, N. D. (2007). Do individuals with a severe mental illness experience greater alcohol and drug-related problems? A test of the supersensitivity hypothesis. Addictive Behaviors, 32(3), 477–490.
Koskinen, J., Löhönen, J., Koponen, H., Isohanni, M., & Miettunen, J. (2009). Prevalence of alcohol use disorders in schizophrenia—a systematic review and meta-analysis. Acta Psychiatrica Scandinavica, 120(2), 85–96.
Kreyenbuhl, J., Nossel, I. R., & Dixon, L. B. (2009). Disengagement from mental health treatment among individuals with schizophrenia and strategies for facilitating connections to care: a review of the literature. Schizophrenia Bulletin, 35(4), 696–703. https://doi.org/10.1093/schbul/sbp046.
McDonell, M. G., Srebnik, D., Angelo, F., McPherson, S., Lowe, J. M., Sugar, A., et al. (2013). Randomized controlled trial of contingency management for stimulant use in community mental health patients with serious mental illness. American Journal of Psychiatry, 170(1), 94–101.
McDonell, M. G., Skalisky, J., Leickly, E., McPherson, S., Battalio, S., Nepom, J. R., et al. (2015). Using ethyl glucuronide in urine to detect light and heavy drinking in alcohol dependent outpatients. Drug and Alcohol Dependence, 157, 184–187.
McDonell, M. G., Leickly, E., McPherson, S., Skalisky, J., Srebnik, D., Angelo, F., et al. (2017). A randomized controlled trial of ethyl glucuronide-based contingency management for outpatients with co-occurring alcohol use disorders and serious mental illness. American Journal of Psychiatry, 174, 370–377.
McGovern, M. P., Clark, R. E., & Samnaliev, M. (2007). Co-occurring psychiatric and substance use disorders: a multistate feasibility study of the quadrant model. Psychiatric Services, 58(7), 949–954.
Oluwoye, O., Hirchak, K., Leickly, E., Skalisky, J., McPherson, S., Srebnik, D., Roll, J.M., Ries, R.K., McDonell, M.G. (Under Review). Co-occurring stimulant use disorders and serious mental illness associated with poor treatment outcomes.
Regier, D. A., Farmer, M. E., Rae, D. S., Locke, B. Z., Keith, S. J., Judd, L. L., & Goodwin, F. K. (1990). Comorbidity of mental disorders with alcohol and other drug abuse: results from the epidemiologic catchment area (ECA) study. JAMA, 264(19), 2511–2518.
Ries, R. (1993). Clinical treatment matching models for dually diagnosed patients. Psychiatric Clinics of North America, 16(1), 167–175.
Sheehan, D. V., Lecruibier, Y., Sheehan, K. H., Amorim, P., Janavs, J., Weiller, E., et al. (1998). The miniinternational neuropsychiatric interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSMM-IV and ICD-10. J Clin Psychiatry. 59, 22–57.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Informed Consent
All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000 (5). Informed consent was obtained from all patients for being included in the study.
Disclosures
OO, EL, JS, KH, DS, and MM have no disclosures to report. SM and JR have received research funding from the Bristol-Myers Squibb Foundation. SM has also received funding from the Orthopedic Specialty Institute. This funding is in no way related to the investigation reported here. SM and JR have no disclosures to report. RR has been on the speaker of bureaus of Janssen, Alkermes, and Reckitt Benckiser in the past 3 years but has no disclosures to report.
Rights and permissions
About this article
Cite this article
Oluwoye, O., Leickly, E., Skalisky, J. et al. Serious Mental Illness in Heavy Drinkers Is Associated with Poor Treatment Outcomes in Outpatients with Co-occurring Disorders. Int J Ment Health Addiction 16, 672–679 (2018). https://doi.org/10.1007/s11469-017-9821-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11469-017-9821-4